MA
MDLN

Modus Advisors’s Medline Inc MDLN Stock Holding History

Modus Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-274
Closed -$11.5K – 357
2025
Q4 		$11.5K Buy
+274
New +$11.6K ﹤0.01% 261

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Modus Advisors's MDLN Position: Q1 2026 in Review

Modus Advisors sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 274 shares — an estimated $11.5K sold.

Modus Advisors first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $11.5K in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Modus Advisors reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 274 Medline Inc shares in Q1 2026, an estimated $11.5K.
  • Modus Advisors first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
  • Modus Advisors's Medline Inc position peaked at $11.5K in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.